Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

International News In Brief

This article was originally published in The Gray Sheet

Executive Summary

U.K. medical products enforcement: The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) published a new 1strategy for enforcing medical device and drug legislation June 18. MHRA is also actively considering extending its "toolkit of sanctions," based on a recent review that found sanctions were too limited and predicated on criminal prosecution

You may also be interested in...



U.K. Strategy Recommends New Legal Powers For Device Enforcement

British regulators are considering new sanctions for device and drug companies that break the law, including administrative money penalties and legally binding agreements specifying corrective actions

U.K. Strategy Recommends New Legal Powers For Device Enforcement

British regulators are considering new sanctions for device and drug companies that break the law, including administrative money penalties and legally binding agreements specifying corrective actions

NICE To Seek Candidates For New-Tech Evaluation Program In First Half Of '10

Device and diagnostics companies should start thinking about products they would like to offer for evaluation under a new program in the U.K

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel